吴黎川 - 广西大学

个人简介

吴黎川，1.2017-至今：广西大学医学院 2.2015.3-2017.3：广西大学化学化工学院，博士后 3.2008.9-2014.7：中国科学院动物研究所，博士 4.2004.9-2008.6：武汉大学，学士主讲课程1.《医学细胞生物学》 2.《生理学》主持（或参与）的主要科研项目1.广西自然科学基金青年科学基金，2017GXNSFBA198240，苦参碱衍生物LC-1逆转鼻咽癌细胞耐药的机制研究，2017/09-2020/09，10万元，在研，主持 2.广西自然科学基金面上项目，2018GXNSFAA050055，NPNT调控AKT促进肝癌上皮间充质转化（EMT）及转移的分子机制，2019/03-2022/02，12万元，在研，主持 3.广西科技厅强基计划项目，镉促进鼻咽癌细胞迁移与侵袭的实验研究，2018/01-2019/12，4万元，在研，主持 4.第三军医大学电磁辐射医学防护教育部重点实验室开放课题基金，2018/01-2019/12,4万元，在研，主持 5.广西师范大学药用资源化学与药物分子工程国家重点实验室开放课题基金，4万元，在研，主持 6.国家自然科学基金青年科学基金项目，61805049，低功率激光氧化损伤的乳腺肿瘤细胞调控免疫应答的研究，2019/01-2021/12，23万元，在研，参加 7.国家自然科学基金地区科学基金，21763004，电刺激控制联合释放Dex与NGF的三维神经电极材料的研究，2018/01-2021/12，38万元，在研，参加

研究领域

肿瘤发病机理及药理学研究

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

(1)YimingXu＃,LichuanWu＃,HaroonUrRashid,DewangJing,XiaoleLiang,HaodongWang,XuLiu,JunJiang,LishengWang*,PengXie*.Novelindolo-sophoridinicscaffoldasTopoIinhibitors:Design,synthesisandbiologicalevaluationasanticanceragents.EurJMedChem,156(2018)479-492. (2)LiZ#,LuoMY#,CaiB#,Haroon-Ur-Rashid,HuangMT,JiangJ,WangLS*,WuLC*.Design,synthesis,biologicalevaluationandstructure-activityrelationshipofsophoridinederivativesbearingpyrroleorindolescaffoldaspotentialantitumoragents.EurJMedChem,157(2018)665-682. (3)ZhengLi＃,LichuanWu＃,BinCai,MengyangLuo,MengtianHuang,HaroonUrRashid,YuwenYang,JunJiang*,LishengWang*.Design,synthesis,andbiologicalevaluationofthiomatrinederivativesaspotentialanticanceragents.MedChemRes,27(2018)1941-1955. (4)YimingXu＃,LichuanWu＃,HangDai,MingyanGao,HaroonUrRashid,HaodongWang,PengXie,XuLiu,JunJiang*,LishengWang*,Novel,β-UnsaturatedSophoridinicDerivatives:Design,Synthesis,MolecularDockingandAnti-CancerActivities,Molecules,2017,22(11),pii:E1967. (5)LichuanWu＃,*,GuizhenWang＃,JinruiWei＃,NaHuang＃,SenZhang,FangfangYang,MingLi,GuangbiaoZhou,LishengWang*,MatrineDerivativeYF-18InhibitsLungCancerCellProliferationandMigrationThroughDown-RegulatingSkp2,Oncotarget,2017,8(7),11729-11738. (6)JingfenLi＃,DongLi＃,YimingXu,ZhenboGuo,XuLiu,HuaYang,LichuanWu*,LishengWang*,Design,Synthesis,BiologicalEvaluation,andMolecularDockingofChalconeDerivativesasAnti-InflammatoryAgents,BioorgMedChemLett,2017,27(3):602-606. (7)LiheJiang＃,LichuanWu＃,FangfangYang＃,NadinAlmosnid,XuLiu,JunJiang,ElliotAltman,LishengWang*,YingGao*,Synthesis,biologicalevaluationandmechanismstudiesofmatrinederivativesasanticanceragents,OncolLett,2017,14:3057-3064. (8)LichuanWu＃,GuizhenWang＃,ShuaibingLiu＃,JinruiWei＃,SenZhang,MingLi,GuangbiaoZhou*,LishengWang*,SynthesisandBiologicalEvaluationofMatrineDerivativesContainingBenzo-Alpha-PyroneStructureasPotentAnti-lungCancerAgents,SciRep,2016,6:35918. (9)LichuanWu＃,ShuaibingLiu＃,JinruiWei,DongLi,XuLiu,JianyiWang,LishengWang*,SynthesisandBiologicalEvaluationofMatrineDerivativesasAnti-HepatocellularCancerAgents,BioorgMedChemLett,2016,26(17):4267-4271. (10)JingfenLi＃,YongYin＃,LishengWang,PengyunLiang,MenghuaLi,XuLiu,LichuanWu*,HuaYang*,Synthesis,Characterization,andAnti-InflammatoryActivitiesofMethylSalicylateDerivativesBearingPiperazineMoiety,Molecules,2016,21(11),pii:E1544. (11)LichuanWu＃,LiangxiaGuo＃,YuehuiLiang,XuLiu,LiheJiang,LishengWang*,CurcuminSuppressesStem-LikeTraitsofLungCancerCellsviaInhibitingtheJAK2/STAT3SignalingPathway,OncolRep,2015,34(6):3311-3317. (12)XianjunYu＃,MinjunYang＃,BoZhou＃,GuizhenWang＃,YunchaoHuang＃,LichuanWu＃,XinCheng,ZheshengWen,JinyanHuang,YundongZhang,XiaohongGao,GaofengLi,ShuiwangHe,ZhaohuiGu,LiangMa,ChunmingPan,PingWang,HaobinChen,ZhipengHong,XiaoluWang,WenjingMao,XiaolongJin,HuiKang,ShutingChen,YongqiangZhu,WenyiGu,ZiLiu,HuiDong,LinweiTian,SaijuanChen*,YiCao*,ShengyueWang*,GuangbiaoZhou*,CharacterizationofSomaticMutationsinAirPollution-RelatedLungCancer,EBioMedicine,2015,2(6):583-590. (13)LichuanWu,ZheshengWen,YataoQiu,XiaoqinChen,HaobinChen,MingmingWei,ZiLiu,ShengJiang,GuangbiaoZhou*,LargazoleArrestsCellCycleatG1PhaseandTriggersProteasomalDegradationofE2F1inLungCancerCells,AcsMedChemLett,2013,4(10):921-926.

学术兼职

SCI期刊OncologyReports、OncologyLetters审稿人